CERo Therapeutics Holdings, Inc. Common Stock

CERo Therapeutics Holdings, Inc. is an immunotherapy company that develops engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.